Jun 30, 2023, 19:08
Perioperative Nivolumab and Chemotherapy in stage III Non-Small-Cell Lung Cancer
In a post by Rami Manochakian on Twitter, it says, “Just published NEJM Results of NADIM II, phase 2 clinical trial, comparing Neoadjuvant nivolumab plus chemotherapy vs chemotherapy alone in patients with resectable stage IIIA or IIIB Non-Small Cell Lung Cancer.”
For article: Click here
Source: Rami Manochakian/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14